|
|
|
MIRA INFORM REPORT
|
Report No. : |
485080 |
|
Report Date : |
15.01.2018 |
IDENTIFICATION DETAILS
|
Name : |
FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Shop No. 5, Mahavir Apartments, Plot No. 30/C, Sector 20, Airoli, Navi Mumbai - 400708, Maharashtra |
|
Tel. No.: |
91-22-27781651/ 2/ 3/ 4 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2016 |
|
|
|
|
Date of
Incorporation : |
09.08.2011 |
|
|
|
|
Com. Reg. No.: |
11-220700 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 1.326 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U74120MH2011PTC220700 |
|
|
|
|
IEC No.: |
Not Divulged |
|
|
|
|
GSTIN/UIN: |
27AABCF8053E1ZR |
|
|
|
|
TIN No.: |
27290865756 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
AABCF8053E |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Subject is engaged into the business of Manufacturing and Marketing of
Pharma Products like Oncology, Hormone, Speciality Injectables and Oral
Drugs. [Registered
Activity] |
|
|
|
|
No. of Employees
: |
Information denied by the management |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A |
|
Credit Rating |
Explanation |
Rating Comments |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
Maximum Credit Limit : |
USD 134440 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject was incorporated in the year 2011. It is a Manufacturing and Marketing
of Pharma Products like Oncology, Hormone, Speciality Injectables and Oral
Drugs. Management has failed to file its financials with the Registrar of
Companies for the year FY 2017. For the financial year 2016, the company has achieved revenue growth
of 25.06% as compared to the previous year along with an average profit
margin of 5.51%. The satisfactory financial risk profile of the company is marked by
adequate net worth base along with low debt balance sheet profile. Rating takes into consideration the subject’s healthy Earnings Per
Share of INR 128.35 against the Face Value of INR 10. Payments are reported to be usually correct. In view of aforesaid, the company can be considered for business
dealings at usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.06.2017) |
Current Rating (30.09.2017) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
NOT AVAILABLE
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 15.01.2018
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION DENIED
MANAGEMENT NON-COOPERATIVE (91-22-40659203)
LOCATIONS
|
Registered Office : |
Shop No. 5, Mahavir Apartments, Plot No. 30/C, Sector 20, Airoli, Navi Mumbai - 400708, Maharashtra, India |
|
Tel. No.: |
91-22-27781651/ 2/ 3/ 4 |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Corporate Office : |
1204 and 1302, Rupa Solitaire, Plot No A-1, Sector – 1, MBP, T.T.C. Industrial, Mahape, Navi Mumbai-400701, Maharashtra, India |
|
Tel. No.: |
91-22-40659200 (Board)/ 40659228 (Marketing)/ 40659203 |
|
E-Mail : |
|
|
|
|
|
Manufacturing Units : |
Located at: · Tarapur Near Mumbai (Maharashtra, India) · Navsari, Naroda (Gujrat, India) · Baddi (Himachal Pradesh, India) |
DIRECTORS
AS ON 31.03.2017
|
Name : |
Mr. Kedar Avinash Vidhwans |
|
Designation : |
Director |
|
Address : |
D 304, 3rd Floor, Sita Vihar, LBS Road, Naupada, Thane
400602, Maharashtra, India |
|
Date of Birth/Age : |
08.06.1978 |
|
Date of Appointment : |
09.08.2011 |
|
DIN No.: |
03554442 |
|
|
|
|
Name : |
Mr. Shailesh Dilipbhai Patel |
|
Designation : |
Director |
|
Address : |
Flat No B 702, Sawan Reside, Kharghar, Navi Mumbai 410210,
Maharashtra, India |
|
Date of Birth/Age : |
29.11.1976 |
|
Date of Appointment : |
09.08.2011 |
|
DIN No.: |
03554471 |
|
|
|
|
Name : |
Mrs. Tejaswini Kedar Vidwans |
|
Designation : |
Director |
|
Address : |
D-304, Sita Vihar, Damani Estate, Naupada, Thane 400099,
Maharashtra, India |
|
Date of Birth/Age : |
02.10.1981 |
|
Date of Appointment : |
09.08.2011 |
|
DIN No.: |
03560823 |
|
|
|
|
Name : |
Mrs. Dipaben Shailesh Patel |
|
Designation : |
Director |
|
Address : |
27, Mohannagar Society Naroda, Ahmedabad 382325, Gujarat,
India |
|
Date of Birth/Age : |
25.12.1979 |
|
Date of Appointment : |
09.08.2011 |
|
DIN No.: |
03560824 |
|
|
|
|
Name : |
Mrs. Prema Jesuwin Cherian |
|
Designation : |
Director |
|
Address : |
A/1201, Lotus Whispering Meadows, Model Town Veena Nagar
Phase 2, Mulund West, Mumbai 400080, Maharashtra, India |
|
Date of Appointment : |
09.08.2011 |
|
DIN No.: |
03560828 |
|
|
|
|
Name : |
Mr. Jesuwin Agnal Cherian |
|
Designation : |
Director |
|
Address : |
A/1201, Lotus Whispering Meadows, Model Town Veena Nagar
Phase 2, Mulund West, Mumbai 400080, Maharashtra, India |
|
Date of Appointment : |
02.05.2014 |
|
DIN No.: |
06840723 |
MAJOR SHAREHOLDERS
AS ON 31.03.2016
|
Names of Shareholders |
No. of Shares |
% of Holding |
|
Kedar Avinash Vidwans |
22100 |
16.67 |
|
Shailesh Dilipbhai Patel |
22100 |
16.67 |
|
Tejaswini Kedar Vidwans |
22100 |
16.67 |
|
Dipaben Shailesh Patel |
22100 |
16.67 |
|
Prema Jesuwin Cherian |
44200 |
33.33 |
|
|
|
|
|
Total |
132600 |
100.00 |
AS ON 30.09.2016
Equity Share Break up (Percentage of Total Equity)
|
Category |
Percentage of
Holding |
|
Promoters- Individual/Hindu Undivided Family- Indian |
100.00 |
|
|
|
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject is engaged into the business of Manufacturing and Marketing of
Pharma Products like Oncology, Hormone, Speciality Injectables and Oral
Drugs. [Registered
Activity] |
||||
|
|
|
||||
|
Products / Services
: |
|
||||
|
|
|
||||
|
Brand Names : |
Not Available |
||||
|
|
|
||||
|
Agencies Held : |
Not Available |
||||
|
|
|
||||
|
Exports : |
Not Divulged |
||||
|
|
|
||||
|
Imports : |
Not Divulged |
||||
|
|
|
||||
|
Terms : |
|
||||
|
Selling : |
Not Divulged |
||||
|
|
|
||||
|
Purchasing : |
Not Divulged |
PRODUCTION STATUS – (NOT AVAILABLE)
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
|
No. of Employees : |
Information denied by the management |
||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
|
Bankers : |
· Kotak Mahindra Bank Limited 27 BKC, C 27, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400051, Maharashtra, India · HDFC Bank Limited HDFC Bank House, Senapati Bapat Marg, Lower Parel [West], Mumbai – 400013, Maharashtra, India · RBL Bank Limited Shahupuri, Kolhapur – 416001, Maharashtra, India |
||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
|
Facilities : |
(INR
In Million)
|
|
Auditors : |
|
|
Name : |
Dinesh Kelkar and Associates Chartered Accountants |
|
Address : |
A/101, Anmol, Sahakar Colony, Brahmin Society, Naupada, Thane – 400602, Maharashtra, India |
|
Tel. No.: |
91-22-25425527 |
|
Mobile No.: |
91-9821332959 |
|
Income-tax
PAN of auditor or auditor's firm : |
ABDPK7414Q |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Associate Company : |
Divine Laboratories Private Limited |
|
|
|
|
Partnership Firm in which directors are interested : |
Flagship Biotech International |
CAPITAL STRUCTURE
AS ON 31.03.2016
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
1080000 |
Equity Shares |
INR 10/- each |
INR 10.800 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
132600 |
Equity Shares |
INR 10/- each |
INR 1.326 Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
INR Million]
ABRIDGED
BALANCE SHEET
|
SOURCES
OF FUNDS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
1.326 |
1.326 |
1.105 |
|
(b) Reserves & Surplus |
45.728 |
28.708 |
14.422 |
|
(c) Money received against
share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
47.054 |
30.034 |
15.527 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
9.585 |
0.000 |
6.116 |
|
(b) Deferred tax liabilities
(Net) |
0.000 |
0.000 |
0.000 |
|
(c) Other long term
liabilities |
0.676 |
0.146 |
0.000 |
|
(d) long-term provisions |
0.000 |
0.000 |
0.000 |
|
Total
Non-current Liabilities (3) |
10.261 |
0.146 |
6.116 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
33.715 |
30.051 |
7.030 |
|
(b) Trade payables |
48.579 |
18.716 |
24.204 |
|
(c) Other current liabilities |
29.599 |
20.825 |
0.000 |
|
(d) Short-term provisions |
0.870 |
0.006 |
4.303 |
|
Total
Current Liabilities (4) |
112.763 |
69.598 |
35.537 |
|
|
|
|
|
|
TOTAL |
170.078 |
99.778 |
57.180 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
18.083 |
20.191 |
22.812 |
|
(ii) Intangible Assets |
0.000 |
0.000 |
0.000 |
|
(iii) Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
(iv) Intangible assets under
development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
27.382 |
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
0.000 |
0.000 |
0.000 |
|
(e) Other Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total
Non-Current Assets |
45.465 |
20.191 |
22.812 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
0.250 |
0.000 |
0.000 |
|
(b) Inventories |
12.537 |
8.784 |
6.638 |
|
(c) Trade receivables |
63.118 |
26.235 |
19.913 |
|
(d) Cash and cash equivalents |
43.053 |
37.124 |
5.273 |
|
(e) Short-term loans and
advances |
4.216 |
5.855 |
1.880 |
|
(f) Other current assets |
1.439 |
1.589 |
0.664 |
|
Total
Current Assets |
124.613 |
79.587 |
34.368 |
|
|
|
|
|
|
TOTAL |
170.078 |
99.778 |
57.180 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
||
|
|
SALES |
|
|
|
||
|
|
|
Revenue from Operations |
309.066 |
247.142 |
144.187 |
|
|
|
|
Other Income |
13.501 |
6.327 |
8.623 |
|
|
|
|
TOTAL (A) |
322.567 |
253.469 |
152.810 |
|
|
|
|
|
|
|
||
|
Less |
EXPENSES |
|
|
|
||
|
|
|
Purchase of Goods |
162.273 |
140.007 |
72.801 |
|
|
|
|
Increase/ (Decrease) in Inventory |
(3.753) |
(2.146) |
(4.745) |
|
|
|
|
Employee Benefits Expenses |
45.260 |
24.996 |
9.244 |
|
|
|
|
Other Expenses |
87.593 |
65.595 |
57.121 |
|
|
|
|
TOTAL (B) |
291.373 |
228.452 |
134.421 |
|
|
|
|
|
|
|
||
|
|
PROFIT/(LOSS)
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
31.194 |
25.017 |
18.389 |
||
|
|
|
|
|
|
||
|
Less |
FINANCIAL
EXPENSES (D) |
2.676 |
0.928 |
1.461 |
||
|
|
|
|
|
|
||
|
|
PROFIT/(LOSS)
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)
(E) |
28.518 |
24.089 |
16.928 |
||
|
|
|
|
|
|
||
|
Less |
DEPRECIATION/
AMORTISATION (F) |
2.469 |
2.897 |
2.934 |
||
|
|
|
|
|
|
||
|
|
PROFIT/(LOSS)
BEFORE TAX (E-F) (G) |
26.049 |
21.192 |
13.994 |
||
|
|
|
|
|
|
||
|
Less |
TAX (H) |
9.029 |
6.906 |
4.625 |
||
|
|
|
|
|
|
||
|
|
PROFIT/(LOSS)
AFTER TAX (G-H) (I) |
17.020 |
14.286 |
9.369 |
||
|
|
|
|
|
|
||
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
||
|
|
|
Export Earnings |
296.862 |
242.743 |
NA |
|
|
|
|
|
|
|
||
|
|
Earnings /
(Loss) Per Share (INR) |
128.35 |
107.74 |
84.79 |
||
CURRENT MATURITIES
OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Current Maturities of Long term debt |
NA |
NA |
NA |
|
|
|
|
|
|
Cash generated from operations |
NA |
NA |
NA |
|
|
|
|
|
|
Net cash flows from (used in) operations |
NA |
NA |
NA |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Average Collection Days (Sundry
Debtors / Income * 365 Days) |
74.54 |
38.75 |
50.41 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry Debtors) |
4.90 |
9.42 |
7.24 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors / Purchases * 365 Days) |
109.27 |
48.79 |
121.35 |
|
|
|
|
|
|
Inventory Turnover (Operating Income / Inventories) |
2.49 |
2.85 |
2.77 |
|
|
|
|
|
|
Asset Turnover (Operating Income / Net Fixed Assets) |
1.73 |
1.24 |
0.81 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Debt Ratio ((Borrowing
+ Current Liabilities) / Total Assets) |
0.72 |
0.70 |
0.73 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability / Networth) |
0.92 |
1.00 |
0.85 |
|
|
|
|
|
|
Current Liabilities to Networth (Current Liabilities / Net Worth) |
2.40 |
2.32 |
2.29 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets / Networth) |
0.38 |
0.67 |
1.47 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial Charges) |
11.66 |
26.96 |
12.59 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Net Profit Margin ((PAT / Sales) * 100) |
% |
5.51 |
5.78 |
6.50 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total Assets) * 100) |
% |
10.01 |
14.32 |
16.39 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth) * 100) |
% |
36.17 |
47.57 |
60.34 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Current Ratio (Current
Assets / Current Liabilities) |
1.11 |
1.14 |
0.97 |
|
|
|
|
|
|
Quick Ratio ((Current Assets – Inventories) / Current
Liabilities) |
0.99 |
1.02 |
0.78 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total Assets) |
0.28 |
0.30 |
0.27 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity Capital) |
32.65 |
22.66 |
11.90 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current Assets / Total Current Liabilities) |
1.11 |
1.14 |
0.97 |
Total
Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term
debts
FINANCIAL ANALYSIS
[all figures are
INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
INR
In Million |
INR
In Million |
INR In
Million |
|
Share Capital |
1.105 |
1.326 |
1.326 |
|
Reserves & Surplus |
14.422 |
28.708 |
45.728 |
|
Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Net
worth |
15.527 |
30.034 |
47.054 |
|
|
|
|
|
|
long-term borrowings |
6.116 |
0.000 |
9.585 |
|
Short term borrowings |
7.030 |
30.051 |
33.715 |
|
Total
borrowings |
13.146 |
30.051 |
43.300 |
|
Debt/Equity
ratio |
0.847 |
1.001 |
0.920 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales |
144.187 |
247.142 |
309.066 |
|
|
|
71.404 |
25.056 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales |
144.187 |
247.142 |
309.066 |
|
Profit |
9.369 |
14.286 |
17.020 |
|
|
6.50% |
5.78% |
5.51% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
No |
|
8 |
Designation of contact person |
No |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
No |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
No |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
No |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
No |
|
32 |
Litigations that the firm/promoter
involved in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
UNSECURED LOANS:
|
Particulars |
31.03.2016 INR In Million |
31.03.2015 INR In Million |
|
SHORT TERM
BORROWING |
|
|
|
Loans form Directors |
12.901 |
10.890 |
|
Other Loans |
0.000 |
3.100 |
|
|
|
|
|
Total |
12.901 |
13.990 |
INDEX OF CHARGES:
|
CHARGES REGISTERED |
||||||||
|
SNO |
SRN |
CHARGE ID |
CHARGE HOLDER NAME |
DATE OF CREATION |
DATE OF MODIFICATION |
DATE OF SATISFACTION |
AMOUNT |
ADDRESS |
|
1 |
G20567178 |
100058846 |
KOTAK MAHINDRA BANK LIMITED |
07/10/2016 |
- |
- |
28300000.0 |
27BKC, C 27, G BLOCKBANDRA KURLA COMPLEX, BANDRA (E),MUMBAIMA400051IN |
|
2 |
G23990104 |
100063717 |
HDFC BANK LIMITED |
20/09/2016 |
- |
- |
10000000.0 |
HDFC BANK HOUSESENAPATI BAPAT MARGLOWER PAREL WMUMBAIMH400013IN |
|
3 |
G06269864 |
100034850 |
RBL BANK LIMITED |
31/05/2016 |
- |
- |
3400000.0 |
SHAHUPURI,KOLHAPUR,KOLHAPURMA416001IN |
|
4 |
B59340463 |
10379621 |
HDFC BANK LIMITED |
21/08/2012 |
- |
- |
10000000.0 |
HDFC BANK HOUSESENAPATI BAPAT MARGLOWER PAREL WMUMBAIMH400013IN |
CORPORATE
INFORMATION
The company is engaged into the business of manufacturing and marketing
of pharma products like Oncology, Hormone, Speciality Injectables and Oral
Drugs.
OPERATING
PERFORMANCE/ STATE OF COMPANY’S AFFAIRS:
During the year, total income of the company was INR 322.567 Million as
compared to INR 253.468 Million during the previous year.
FIXED ASSETS:
· Office Premises
· Furniture and Fixture
· Vehicles
· Computers and Printers
· Server
· Office Equipment
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals have
been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 63.53 |
|
|
1 |
INR 86.05 |
|
Euro |
1 |
INR 76.53 |
INFORMATION DETAILS
|
Information
Gathered by : |
PRY |
|
|
|
|
Analysis Done by
: |
PRT |
|
|
|
|
Report Prepared
by : |
BVA |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.